The compensation the Serbian tennis player will seek includes the prize money he would have won had he stayed in Melbourne and won his 10th Australian Open title Tennis Australia denies paying for Djokovic's legal bills
Novak Djokovic is reportedly preparing to take legal action against the Australian government for his deportation. The world No. 1 tennis player was forced to leave Melbourne on the eve of the Australian Open after an 11-day battle with authorities over a visa.
The 20-time Grand Slam winner is back in Serbia and is discussing with his lawyers the possibility of suing the Australian government seeking more than $6 million for "mistreatment," according to a Sun report.
The claims come as Tennis Australia denied reports that it paid Djokovic's legal bills ($500,000) during his legal battle to stay in the country.
It has been claimed that Tennis Australia paid for Novak Djokovic's flights, accommodation and legal fees during the tennis stars ill-fated trip to Melbourne. pic.twitter.com/EBQuuzIFXu
- Sunrise (@sunriseon7) January 19, 2022
[BR]
The compensation Nole will seek includes the prize money he would win if he stayed in Melbourne and won his 10th Australian Open title (approximately $2.5 million).
According to the Serbian tennis player's family and legal representatives, Djokovic was subjected to humiliating treatment by the Australian government mainly because of his stay in the migrant quarantine hotel before his visa was cancelled for the second time following the legal battle over his failure to be vaccinated against COVID-19.
At the same time, Reuters revealed that the unvaccinated tennis player had bought 80% of a company in Denmark that is working on making a drug to fight coronavirus. QuantBioRes has about 11 researchers working in Denmark, Australia and Slovenia, according to the company's CEO Ivan Lonkarevic, who told the agency that their research is on a cure for Covid-19 and not a vaccine.
Novak Djokovic has purchased 80% of Danish biotech firm QuantBioRes, aiming to develop a medical treatment against COVID-19, the companys chief executive told Reuters https:/t.co/XxHGtD0Ud2 pic.twitter.com/XrOzknZmHL
- Reuters (@Reuters) January 19, 2022
Πηγή: protothema.gr
Contents of this article including associated images are belongs Cyprus Times
Views & opinions expressed are those of the author and/or Cyprus Times
Source[/P]